总部位于瑞士的生物技术初创公司 Polaroid Therapeutics 完成了临床前里程碑。 Swiss-based biotech start-up Polaroid Therapeutics completes pre-clinical milestone.

Polaroid Therapeutics 是一家总部位于瑞士的生物技术初创公司，在开发用于治疗急性和慢性伤口的创新聚合物技术方面已经完成了临床前里程碑。 Polaroid Therapeutics, a Swiss-based biotech start-up, has completed pre-clinical milestones in the development of an innovative polymer technology for treating acute and chronic wounds. 抗菌技术可以大幅减少细菌生物负载，而不会导致抗菌素耐药性，而抗菌素耐药性是全球最大的公共卫生威胁之一。 The antimicrobial technology can substantially reduce bacterial bioburden without contributing to antimicrobial resistance, which is one of the top global public health threats. 高级伤口敷料市场目前价值 45 亿美元，需求不断增长，技术不断进步。 The Advanced Wound Dressing market is currently valued at $4.5 billion and is witnessing rising demand and technological advancements.